Media Summary: Jill Corre, PharmD, PhD, of L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, ... The virtual AML Hub Satellite Symposium at the 46th Annual Meeting of the European Society for Blood and Marrow ... During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Danielle Hammond, ...
Measuring Mrd Methods And Challenges - Detailed Analysis & Overview
Jill Corre, PharmD, PhD, of L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, ... The virtual AML Hub Satellite Symposium at the 46th Annual Meeting of the European Society for Blood and Marrow ... During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Danielle Hammond, ... Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses the ... Here, Robin Foà, MD, from Sapienza University of Rome, Rome, Italy, talks about the Ola Landgren, MD, PhD, from Memorial Sloan Kettering Cancer Center, NY, describes novel uses for minimal residual disease ...
Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Gert J. Ossenkoppele, MD, PhD of VU University Medical Center, Amsterdam, Netherlands discusses the Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses the value of using next-generation flow cytometry to ... James Blachly, MD, The Ohio State University, Columbus, OH, discusses measurable residual disease ( Selina Luger, MD, University of Pennsylvania, Philadelphia, PA, talks about the importance of minimal residual disease ( Jerald P. Radich, MD, member, Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Research ...
One of the controversies surrounding the use of minimal residual disease ( Harry Erba, MD, PhD, Duke University, Durham, NC, discusses the potential of measurable residual disease ( Webinar presenter Rashmi Kanagal-Shamanna, MD, Associate Professor, Department of Hematopathology, Director, Molecular ...
